BridgeMD
New treatment option for Obstructive Sleep Apnea
Official title Precision Health and Smart Telerehabilitation in OSA
ClinicalTrials.gov ID: NCT07254026
What this study is testing
- What it's testing
- This study aims to improve treatment strategies for Obstructive Sleep Apnea (OSA), a disorder characterized by recurrent upper airway collapse during sleep, resulting in reduced oxygenation, sleep fragmentation, and excessive daytime sleepiness. The objectives are twofold: to evaluate whether an artificial intelligence (AI)-based model can accurately predict the most effective treatment for individual patients, and to assess whether a mobile health application can enhance adherence to oropharyngeal rehabilitation (OPR) and improve therapeutic outcomes.
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- 20 years old and above
- Newly diagnosed with mild to severe pure obstructive sleep apnea based on polysomnography
You likely can't join if
- Severe allergic rhinitis
- Sinusitis with nasal polyps
- Body Mass Index (BMI) \> 31
- Alcohol or drug abuse within the past year
- Pregnancy
- Severe obstructive or restrictive pulmonary diseases
See the full eligibility criteria
- 20 years old and above
- Newly diagnosed with mild to severe pure obstructive sleep apnea based on polysomnography
- Severe allergic rhinitis
- Sinusitis with nasal polyps
- Body Mass Index (BMI) \> 31
- Alcohol or drug abuse within the past year
- Pregnancy
- Severe obstructive or restrictive pulmonary diseases
- High-risk cardiovascular diseases during exercise (e.g., angina, myocardial infarction, heart failure, valvular heart disease)
- History of central or peripheral neurological disorders that interfere with exercise prescription
- Musculoskeletal or psychological disorders that interfere with exercise prescription
- Other non-respiratory sleep disorders
- Sleep disorders with concomitant central sleep apnea
The study team makes the final eligibility decision.
Where it's taking place
- Tainan, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tainan, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.